Allied Market Research
Loading...
0
New
New

Pain Management Devices Market by Type (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, and Ablation Devices) and Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2028

A00088
Pages: 209
Jun 2021 | 21902 Views
   
Author(s) : Trupti Wadekar, Sushant Terdale , Onkar Sumant
Tables: 93
Charts: 54
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pain Management Devices Market

Request Now !

The global pain management devices market was valued at $3,689.20 million in 2020, and is projected to reach $5,767.69 million by 2028, registering a CAGR of 6.3% from 2021 to 2028. Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Pain management devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain, and others.

Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.  

Pain-Management-Devices-Market-2021-2028

Get more information on this report : Request Sample Pages

COVID-19 Impact

This pandemic has disrupted growth in many economies across various domains. The COVID-19 outbreak is expected to impact the growth of the pain management devices market globally. The COVID-19 pandemic has stressed healthcare systems across the globe, so that many clinics, and pain services are open for public services for only a limited period. Large number of hospitals & clinics have witnessed a drop in number of patient visits amid COVID-19 ultimately reducing client contact. Subsequently, most chronic pain facilities were deemed non-urgent, both outpatient and elective interventional procedures were limited or stopped during the COVID-19 pandemic to minimize risk of the viral spread. For instance, according to the Indian Journal of Anesthesia, COVID-19 has a negative impact on the pain clinics, including interventional pain management procedures. Thus, limited availability of medical care for conditions other than COVID-19 has impacted the growth of the pain management devices market in a negative manner. At the same time, limited availability of healthcare staff across the globe is another factor, which has an undesirable effect on the pain management devices market.

Product Segment Review

On the basis of product, the pain management devices market is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. Under the neuromodulation & neurostimulation devices segment, the market is further bifurcated into spinal cord stimulators and transcutaneous electrical nerve stimulation (TENS) devices. Under the analgesic infusion pumps, the pain management devices market is further divided into external infusion pumps and intrathecal infusion pumps. Presently, the neuromodulation & neurostimulation devices dominates the global market, and is anticipated to continue this trend over the forecast period, due surge in demand for neuromodulation & neurostimulation devices, cost efficiency offered by these devices, increase in target population.

Pain Management Devices Market
By Product

Your browser does not support the canvas element.

Neuromodulation and Neurostimulation Devices segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Application Segment Review

By application, the market is classified into neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. At present, the neuropathic pain accounts for a majority of the market share, owing to surge in number of target population, technological advancements in pain management devices, and surge in demand for pain management devices for management of neuropathic pain.

Pain Management Devices Market
By Application

Your browser does not support the canvas element.

Neuropathic Pain segment held a dominant position in 2020 and will continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific Pain Management Devices Market  

Asia-Pacific presents lucrative opportunities for the key players operating in the pain management devices market, owing to surge in awareness about implantable pain management devices and rise in adoption of pain management devices products. Improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, increase in number of target population, rise in healthcare reforms, and technological advancements in the field of healthcare further contribute toward the market growth. Some other factors such as surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high growth potential, presence of large patient base, and high disposable income are expected to drive the growth of the pain management devices market in Asia-Pacific.

Pain Management Devices Market
By Region

2028
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific would exhibit the highest CAGR of 7.9% during 2021-2028.

Get more information on this report : Request Sample Pages

The key players profiled in this report include Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., DJO Global LLC., Johnson & Johnson (Codman And Shurtleff, Inc.,), Kimberly Clark Corporation, Medtronic Plc., Pfizer, Inc., and Stryker Corp.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current pain management devices market trends and forecast estimations from 2020 to 2028, which assists to identify the prevailing market opportunities. 
  • An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
  • The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2028, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the pain management devices market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the global pain management devices market.

Key Market Segments

By Type  

  • Neuromodulation & Neurostimulation Devices o 
    • Spinal Cord Stimulators 
    • Transcutaneous Electrical Nerve Stimulation (TENS) Devices  
  • Analgesic Infusion Pumps 
    • External Infusion Pumps  
    • Intrathecal Infusion Pumps  
  • Ablation Devices 

By Application  

  • Neuropathic Pain  
  • Cancer Pain  
  • Facial & Migraine Pain  
  • Musculoskeletal Pain  
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of chronic diseases
3.5.1.2.Rise in geriatric population
3.5.1.3.Increase in adoption of pain management devices

3.5.2.Restraint

3.5.2.1.Preferable use of medications for pain management

3.5.3.Opportunity

3.5.3.1.Growth opportunities in emerging markets

3.5.4.Impact analysis

3.6.Covid-19 Impact analysis on pain management devices market

CHAPTER 4:PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Neuromodulation & neurostimulation devices

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type

4.2.4.1.Spinal cord stimulators

4.2.4.1.1.Market size and forecast

4.2.4.2.Transcutaneous electrical nerve stimulation (TENS) devices

4.2.4.2.1.Market size and forecast

4.3.Analgesic infusion pumps

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type

4.3.4.1.External infusion pumps

4.3.4.1.1.Market size and forecast

4.3.4.2.Intrathecal infusion pumps

4.3.4.2.1.Market size and forecast

4.4.Ablation devices

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Neuropathic pain

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Cancer pain

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Facial & migraine pain

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Musculoskeletal pain

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

5.6.Other

5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country

CHAPTER 6:PAIN MANAGEMENT DEVICES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. pain management devices market, by product
6.2.2.1.2.U.S. pain management devices market, by application

6.2.2.2.Canada

6.2.2.2.1.Canada pain management devices market, by product
6.2.2.2.2.Canada pain management devices market, by application

6.2.2.3.Mexico

6.2.2.3.1.Mexico pain management devices market, by product
6.2.2.3.2.Mexico pain management devices market, by application

6.2.3.North America market size and forecast, by product
6.2.4.North America market size and forecast, by application

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country

6.3.2.1.Germany

6.3.2.1.1.Germany pain management devices market, by product
6.3.2.1.2.Germany pain management devices market, by application

6.3.2.2.France

6.3.2.2.1.France pain management devices market, by product
6.3.2.2.2.France pain management devices market, by application

6.3.2.3.UK

6.3.2.3.1.UK pain management devices market, by product
6.3.2.3.2.UK pain management devices market, by application

6.3.2.4.Italy

6.3.2.4.1.Italy pain management devices market, by product
6.3.2.4.2.Italy pain management devices market, by application

6.3.2.5.Spain

6.3.2.5.1.Spain pain management devices market, by product
6.3.2.5.2.Spain pain management devices market, by application

6.3.2.6.Rest of Europe

6.3.2.6.1.Rest of Europe pain management devices market, by product
6.3.2.6.2.Rest of Europe pain management devices market, by application

6.3.3.Europe market size and forecast, by product
6.3.4.Europe market size and forecast, by application

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country

6.4.2.1.Japan

6.4.2.1.1.Japan pain management devices market, by product
6.4.2.1.2.Japan pain management devices market, by application

6.4.2.2.China

6.4.2.2.1.China pain management devices market, by product
6.4.2.2.2.China pain management devices market, by application

6.4.2.3.Australia

6.4.2.3.1.Australia pain management devices market, by product
6.4.2.3.2.Australia pain management devices market, by application

6.4.2.4.India

6.4.2.4.1.India pain management devices market, by product
6.4.2.4.2.India pain management devices market, by application

6.4.2.5.South Korea

6.4.2.5.1.South Korea pain management devices market, by product
6.4.2.5.2.South Korea pain management devices market, by application

6.4.2.6.Rest of Asia-Pacific

6.4.2.6.1.Rest of Asia-Pacific pain management devices market, by product
6.4.2.6.2.Rest of Asia-Pacific pain management devices market, by application

6.4.3.Asia-Pacific market size and forecast, by product
6.4.4.Asia-Pacific market size and forecast, by application

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country

6.5.2.1.Brazil

6.5.2.1.1.Brazil pain management devices market, by product
6.5.2.1.2.Brazil pain management devices market, by application

6.5.2.2.Saudi Arabia

6.5.2.2.1.Saudi Arabia pain management devices market, by product
6.5.2.2.2.Saudi Arabia pain management devices market, by application

6.5.2.3.South Africa

6.5.2.3.1.South Africa pain management devices market, by product
6.5.2.3.2.South Africa pain management devices market, by application

6.5.2.4.Rest of LAMEA

6.5.2.4.1.Rest of LAMEA pain management devices market, by product
6.5.2.4.2.Rest of LAMEA pain management devices market, by application

6.5.3.LAMEA market size and forecast, by product
6.5.4.LAMEA market size and forecast, by application

CHAPTER 7:COMPANY PROFILES

7.1.ABBOTT LABORATORIES

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments

7.2.B BRAUN MELSUNGEN AG

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance

7.3.BAXTER INTERNATIONAL INC.

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance

7.4.BOSTON SCIENTIFIC CORPORATION

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments

7.5.COLFAX CORPORATION (DJO GLOBAL LLC)

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.JOHNSON & JOHNSON (CODMAN AND SHURTLEFF, INC.)

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance

7.7.KIMBERLY-CLARK CORPORATION (BAYLIS MEDICAL)

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance

7.8.MEDTRONIC PLC

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments

7.9.PFIZER INC. (HOSPIRA INC.)

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance

7.10.STRYKER CORPORATION

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance

LIST OF TABLES

TABLE 01.PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 02.PAIN MANAGEMENT DEVICES MARKET FOR NEUROMODULATION & NEUROSTIMULATION DEVICES, BY REGION, 2020-2028 ($MILLION)
TABLE 03.PAIN MANAGEMENT DEVICES MARKET FOR NEUROMODULATION & NEUROSTIMULATION DEVICES, BY TYPE, 2020–2028 ($MILLION)
TABLE 04.PAIN MANAGEMENT DEVICES MARKET FOR ANALGESIC INFUSION PUMPS, BY REGION, 2020-2028 ($MILLION)
TABLE 05.PAIN MANAGEMENT DEVICES MARKET FOR ANALGESIC INFUSION PUMPS, BY TYPE, 2020–2028 ($MILLION)
TABLE 06.PAIN MANAGEMENT DEVICES MARKET FOR ABLATION DEVICES, BY REGION, 2020-2028 ($MILLION)
TABLE 07.PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 08.PAIN MANAGEMENT DEVICES MARKET FOR NEUROPATHIC PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 09.PAIN MANAGEMENT DEVICES MARKET FOR CANCER PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 10.PAIN MANAGEMENT DEVICES MARKET FOR FACIAL & MIGRAINE PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 11.PAIN MANAGEMENT DEVICES MARKET FOR MUSCULOSKELETAL PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 12.PAIN MANAGEMENT DEVICES MARKET FOR OTHER PAIN, BY REGION, 2020-2028 ($MILLION)
TABLE 13.PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 14.NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 15.U.S. PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 16.U.S. PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 17.CANADA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 18.CANADA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 19.MEXICO PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 20.MEXICO PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 21.NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 22.NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 23.EUROPE PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 24.GERMANY PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 25.GERMANY PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 26.FRANCE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 27.FRANCE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 28.UK PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 29.UK PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 30.ITALY PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 31.ITALY PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 32.SPAIN PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 33.SPAIN PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 34.REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 35.REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 36.EUROPE PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 37.EUROPE PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 38.ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 39.JAPAN PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 40.JAPAN PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 41.CHINA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 42.CHINA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 43.AUSTRALIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 44.AUSTRALIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 45.INDIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 46.INDIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 47.SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 48.SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 50.REST OF ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 51.ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 52.ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 53.LAMEA PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 54.BRAZIL PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 55.BRAZIL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 56.SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 57.SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 58.SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 59.SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 60.REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 61.REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 62.LAMEA PAIN MANAGEMENT DEVICES MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 63.LAMEA PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 64.ABBOTT: COMPANY SNAPSHOT
TABLE 65.ABBOTT: OPERATING SEGMENTS
TABLE 66.ABBOTT: PRODUCT PORTFOLIO
TABLE 67.B BRAUN: COMPANY SNAPSHOT
TABLE 68.B BRAUN: OPERATING SEGMENTS
TABLE 69.B BRAUN: PRODUCT PORTFOLIO
TABLE 70.BAXTER: COMPANY SNAPSHOT
TABLE 71.BAXTER: OPERATING SEGMENTS
TABLE 72.BAXTER: PRODUCT PORTFOLIO
TABLE 73.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 74.BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 75.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 76.COLFAX: COMPANY SNAPSHOT
TABLE 77.COLFAX: OPERATING SEGMENTS
TABLE 78.COLFAX: PRODUCT PORTFOLIO
TABLE 79.J&J: COMPANY SNAPSHOT
TABLE 80.J&J: OPERATING SEGMENTS
TABLE 81.J&J: PRODUCT PORTFOLIO
TABLE 82.KIMBERLY-CLARK: COMPANY SNAPSHOT
TABLE 83.KIMBERLY-CLARK: OPERATING SEGMENTS
TABLE 84.KIMBERLY-CLARK: PRODUCT PORTFOLIO
TABLE 85.MEDTRONIC: COMPANY SNAPSHOT
TABLE 86.MEDTRONIC: OPERATING SEGMENTS
TABLE 87.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88.PFIZER INC.: COMPANY SNAPSHOT
TABLE 89.PFIZER: OPERATING SEGMENTS
TABLE 90.PFIZER INC.: PRODUCT PORTFOLIO
TABLE 91.STRYKER: COMPANY SNAPSHOT
TABLE 92.STRYKER: OPERATING SEGMENTS
TABLE 93.STRYKER: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.PAIN MANAGEMENT DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.MARKET PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR NEUROMODULATION & NEUROSTIMULATION DEVICES, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 14.SPINAL CORD STIMULATORS MARKET, 2020–2028 ($MILLION)
FIGURE 15.TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES MARKET, 2020–2028 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR ANALGESIC INFUSION PUMPS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 17.EXTERNAL INFUSION PUMPS MARKET, 2020–2028 ($MILLION)
FIGURE 18.INTRATHECAL INFUSION PUMPS MARKET, 2020–2028 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR ABLATION DEVICES, BY COUNTRY,  2020 & 2028 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR CANCER PAIN, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR FACIAL & MIGRAINE PAIN, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF PAIN MANAGEMENT DEVICES MARKET FOR MUSCULOSKELETAL PAIN, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF OTHERS PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 25.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 28.B BRAUN: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.B BRAUN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.B BRAUN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31.BAXTER: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.BAXTER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.BAXTER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34.BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.BOSTON SCIENTIFIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.COLFAX: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.COLFAX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.COLFAX: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 40.J&J: NET SALES, 2018–2020 ($MILLION)
FIGURE 41.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42.J&J: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43.KIMBERLY-CLARK: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.KIMBERLY-CLARK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45.KIMBERLY-CLARK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 46.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 47.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 48.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 49.PFIZER INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 50.PFIZER INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 51.PFIZER INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 52.STRYKER: NET SALES, 2018–2020 ($MILLION)
FIGURE 53.STRYKER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 54.STRYKER: REVENUE SHARE BY REGION, 2020 (%)

 
 

Neuromodulation & neurostimulation devices, analgesic infusion pumps, ablation devices, and electrostimulation devices are widely used in management of chronic pain. Rise in prevalence of chronic pain, technological advancements in pain management devices, increase in popularity of neuromodulation & neurostimulation devices, and surge in demand for pain management devices products significantly boost the growth of the pain management devices market. Moreover, rise in awareness among people toward easy availability of pain management devices, increase in healthcare expenditure, and surge in need for advanced pain management devices fuel the growth of the global pain management devices market.

North America is expected to remain dominant during the forecast period, due to higher adoption of pain management devices with large presence of key players. In addition, availability of advanced facilities and higher number of target population supplement the growth of the market. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, due to surge in target population, development in infrastructure of healthcare industry along with rise in demand for pain management devices.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Pain Management Devices market is $3,689.2 million in 2020.

A. The forcast period for Pain Management Devices market is 2021 to 2028

A. The market value of Pain Management Devices market in 2021 is $3,771.46 million.

A. The base year is 2020 in Pain Management Devices market

A. Top companies such as Abbott Laboratories, Boston Scientific Corp, and Medtronic Plc., B Braun Melsungen AG, Baxter International Inc. , Colfax Corporation (DJO Global LLC) , and Stryker Corp. held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Neuromodulation & neurostimulation devices segment is the most influencing segment owing to rise in prevalence of neurological disorders such as Parkinson’s disease, migraine, and chronic pain with surge in adoption of neurostimulation & neuromodulation devices for management of pain.

A. Significant increase in prevalence of chronic pain, rise in geriatric population, surge in awareness among people toward pain management devices, and increase in demand for pain management devices in developing region are the key factors that fuel the growth of the market. Moreover, availability of innovative pain management devices, surge in R&D activities to develop technologically advanced pain management devices, increase in availability of lower cost portable products, and development of the medical device industry across the globe are other factors that contribute toward the growth of the market.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the improvement in healthcare infrastructure, availability of pain management devices, surge in healthcare reforms, and technological advancements in the field of healthcare. In addition, leading manufacturers have been focusing on expanding their geographical presence in emerging Asia-Pacific countries to capture potential growth opportunities in the market.

A. Pain management is a branch of medical science, which eases the suffering of patients suffering from chronic pain or acute pain.

A. Pain management devices are medical devices, which are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, and musculoskeletal pain.

Allied Market Research Allied Market Research Allied Market Research

RELATED TAGS

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Pain Management Devices Market

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers